9 May 2022 , 08:15 AM
Net profit of Par Drugs & Chemicals declined 0.41% to Rs 2.42 crore in the quarter ended March 2022 as against Rs 2.43 crore during the previous quarter ended March 2021. Sales rose 36.21% to Rs 22.08 crore in the quarter ended March 2022 as against Rs 16.21 crore during the previous quarter ended March 2021. For the full year,net profit declined 20.59% to Rs 9.22 crore in the year ended March 2022 as against Rs 11.61 crore during the previous year ended March 2021. Sales rose 23.57% to Rs 75.07 crore in the year ended March 2022 as against Rs 60.75 crore during the previous year ended March 2021.
Particulars | Quarter Ended | Year Ended | ||||
? | Mar. 2022 | Mar. 2021 | % Var. | Mar. 2022 | Mar. 2021 | % Var. |
Sales | 22.08 | 16.21 | 36 | 75.07 | 60.75 | 24 |
OPM % | 20.43 | 26.59 | – | 21.66 | 26.34 | – |
PBDT | 4.49 | 4.15 | 8 | 15.99 | 15.55 | 3 |
PBT | 3.62 | 3.42 | 6 | 12.71 | 12.73 | 0 |
NP | 2.42 | 2.43 | 0 | 9.22 | 11.61 | -21 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.